EUVIMEDEUVIMED entdecken
Multizentrische Studie

Magnesium Isoglycyrrhizinate Combined With Steroid Is Superior to Steroid Monotherapy in Checkpoint Inhibitor‐Induced Liver Injury

Yang Zhi, Yinuo Dong, Xiaoyun Li, Wei Zhong, Xiaohong Lei, Mingyang Ma iD, Sha Huang, Minyan Ye, Zuxiong Huang, Liqing Zheng, Lanlan He, Qinghui Niu und 5 weitere

Liver International · 2025-09 · 45 (9)

DOI: 10.1111/liv.70310 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, online erschienen am 26.08.2025. Verfasst von Yang Zhi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, NHC Key Laboratory of Digestive Diseas…. Hauptthemen laut MEDLINE: Saponins, Chemical and Drug Induced Liver Injury, Triterpenes, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Major Project of National Thirteenth Five Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Steroids are the standard treatment for checkpoint inhibitor‐induced liver injury (ChILI). However, concerns about their adverse effects and impacts on long‐term outcomes highlight the need for alternative therapies. This study aims to evaluate the effectiveness of magnesium isoglycyrrhizinate (MgIG) in combination with steroids in ChILI.

Methods

A multicentre, retrospective, propensity score matched case–control study was conducted based on electronic medical records in patients with ChILI from December 2019 to December 2022 in five tertiary hospitals. Cases were categorised into combination therapy group and steroid monotherapy group.

Results

A total of 229 cases were included, with 114 in the combination therapy group and 115 in the steroid group. The reduction in ALT on day 10 was significantly greater in the combination group (−148 [−232 to −44] vs. −98 [−239 to 8], p = 0.01). Combination therapy was more likely to achieve ALT normalisation (OR 2.13, 95% CI 1.11–4.09, p = 0.023), and a greater proportion of patients with ≤ grade 1 liver injury (43.9% vs. 24.4%, p = 0.002) on day 10. Notably, MgIG reduced the steroid dose ( p = 0.023) and the proportion of patients requiring high‐dose steroids in patients with high‐grade liver injury (1.1% vs. 9.0%, p = 0.017). Length of stay was shorter in the combination group (15 [10–24] vs. 17 [13–28], p = 0.020).

Conclusion

Combination of MgIG and steroid outperformed steroid monotherapy by accelerating recovery, reducing the dose of steroids, and shortening length of stay in patients with ChILI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SaponinsChemical and Drug Induced Liver InjuryTriterpenesImmune Checkpoint InhibitorsSteroidsHumansMaleFemaleRetrospective StudiesMiddle AgedDrug Therapy, CombinationCase-Control StudiesAgedPropensity ScoreTreatment Outcome

Stichwörter der Autor:innen

chemical and drug induced liver injurydrug‐related side effects and adverse reactionsimmune checkpoint inhibitorsmagnesium isoglycyrrhizinatepropensity scoretherapy

Substanzen

18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesi…SaponinsTriterpenesImmune Checkpoint InhibitorsSteroids

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, NHC Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Shanghai, China.
  • Department of Hepatology, Hepatology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fujian Clinical Research Center for Liver and Intestinal Diseases, Fuzhou, Fujian, China.
  • Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
  • Department of Hepatology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Liver Diseases, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

ORCID-Profile: Mingyang Ma, Yimin Mao

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Major Project of National Thirteenth Five Plan

Zitieren

APA

Zhi, Y., Dong, Y., Li, X., Zhong, W., Lei, X., Ma, M., Huang, S., Ye, M., Huang, Z., Zheng, L., He, L., Niu, Q., Lu, Z., Zhang, J., Yu, Z., Tang, J., & Mao, Y. (2025). Magnesium Isoglycyrrhizinate Combined With Steroid Is Superior to Steroid Monotherapy in Checkpoint Inhibitor‐Induced Liver Injury. Liver International, 45(9). https://doi.org/10.1111/liv.70310

Vancouver

Zhi Y, Dong Y, Li X, Zhong W, Lei X, Ma M, et al. Magnesium Isoglycyrrhizinate Combined With Steroid Is Superior to Steroid Monotherapy in Checkpoint Inhibitor‐Induced Liver Injury. Liver International. 2025;45(9). doi:10.1111/liv.70310

BibTeX
@article{Zhi2025,
  author = {Zhi, Yang and Dong, Yinuo and Li, Xiaoyun and Zhong, Wei and Lei, Xiaohong and Ma, Mingyang and Huang, Sha and Ye, Minyan and Huang, Zuxiong and Zheng, Liqing and He, Lanlan and Niu, Qinghui and Lu, Zhonghua and Zhang, Jinyuan and Yu, Ze and Tang, Jieting and Mao, Yimin},
  title = {Magnesium Isoglycyrrhizinate Combined With Steroid Is Superior to Steroid Monotherapy in Checkpoint Inhibitor‐Induced Liver Injury},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {9},
  doi = {10.1111/liv.70310}
}
Kostenlos starten →